← Open Payments lookup

KARI SHEARMAN: Open Payments

NPI 1316633928 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$287 in 10 payments from 9 companies in 2025. Trend: 2023 $48 · 2024 $260 · 2025 $287

Food & beverage: $287
CompanyPaymentsAmount
TerSera Therapeutics LLC2$57
Janssen Biotech, Inc.1$56
Takeda Pharmaceuticals U.S.A., Inc.1$35
Exelixis Inc.1$29
Ipsen Biopharmaceuticals, Inc1$25
ADC THERAPEUTICS AMERICA, INC.1$22
Merck Sharp & Dohme LLC1$21
Daiichi Sankyo Inc.1$21
PharmaEssentia USA Corporation1$20

Products named: RYBREVANT, FRUZAQLA, CABOMETYX, Xermelo, Zoladex, Onivyde, ZYNLONTA, KEYTRUDA.

Industry payments across DE — which companies pay providers there.